BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 6141175)

  • 1. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
    Lamberts SW; Verleun T; Oosterom R
    J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of growth hormone (GH) secretion by GH-releasing factor, somatostatin, and insulin-like growth factor I in ovine fetal and neonatal pituitary cells in vitro.
    Silverman BL; Bettendorf M; Kaplan SL; Grumbach MM; Miller WL
    Endocrinology; 1989 Jan; 124(1):84-9. PubMed ID: 2562828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human fetal pituitaries.
    Goodyer CG; Branchaud CL; Lefebvre Y
    J Clin Endocrinol Metab; 1993 May; 76(5):1259-64. PubMed ID: 8098715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro modulation of growth hormone (GH) secretion from early to midgestation human fetal pituitaries by GH-releasing factor and somatostatin: role of Gs-adenylate cyclase-Gi complex and Ca2+ channels.
    Goodyer CG; Branchaud CL; Lefebvre Y
    J Clin Endocrinol Metab; 1993 May; 76(5):1265-70. PubMed ID: 8098716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological role of growth hormone (GH)-releasing factor and somatostatin in the dynamics of GH secretion in adult male rat.
    Sato M; Takahara J; Fujioka Y; Niimi M; Irino S
    Endocrinology; 1988 Oct; 123(4):1928-33. PubMed ID: 2901340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture.
    Cuttler L; Welsh JB; Szabo M
    Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro regulation of growth hormone (GH) release from ovine pituitary cells during fetal and neonatal development: effects of GH-releasing factor, somatostatin, and insulin-like growth factor I.
    Blanchard MM; Goodyer CG; Charrier J; Barenton B
    Endocrinology; 1988 May; 122(5):2114-20. PubMed ID: 2896119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion.
    Tannenbaum GS; Ling N
    Endocrinology; 1984 Nov; 115(5):1952-7. PubMed ID: 6149116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone.
    Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P
    Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
    Stachura ME; Tyler JM; Farmer PK
    Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vasoactive intestinal polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues.
    Chihara K; Iwasaki J; Minamitani N; Kaji H; Matsukura S; Tamaki N; Matsumoto S; Fujita T
    J Clin Endocrinol Metab; 1982 Apr; 54(4):773-9. PubMed ID: 6120948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium homeostasis in growth hormone (GH)-secreting adenoma cells: effect of GH-releasing factor.
    Dufy-Barbe L; Bresson L; Sartor P; Odessa MF; Dufy B
    Endocrinology; 1992 Sep; 131(3):1436-44. PubMed ID: 1505473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of growth hormone-releasing factor (1-44) on growth hormone release from human somatotrophinomas in vitro: interaction with somatostatin, dopamine, vasoactive intestinal peptide and cycloheximide.
    White MC; Daniels M; Kendall-Taylor P; Turner SJ; Mathias D; Teasdale G
    J Endocrinol; 1985 May; 105(2):269-76. PubMed ID: 2859345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effects of growth hormone-releasing factor and somatostatin.
    Holl RW; Thorner MO; Leong DA
    Endocrinology; 1988 Jun; 122(6):2927-32. PubMed ID: 2453353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells.
    Fukata J; Diamond DJ; Martin JB
    Endocrinology; 1985 Aug; 117(2):457-67. PubMed ID: 2862007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
    Painson JC; Tannenbaum GS
    Endocrinology; 1991 Jun; 128(6):2858-66. PubMed ID: 1674685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.